Rapid and sustained pain improvement in rheumatoid arthritis patients treated with baricitinib compared to adalimumab or placebo

類似資料

• Baricitinib versus placebo or adalimumab in rheumatoid arthritis
  著者:: Taylor, P, 等
  出版事項: (2017)
• Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
  著者:: Fautrel, B, 等
  出版事項: (2017)
• Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
  著者:: Taylor, P, 等
  出版事項: (2019)
• Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
  著者:: Fautrel, B, 等
  出版事項: (2019)
• Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
  著者:: Taylor, P, 等
  出版事項: (2019)